Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients

Thrombosis Research

Volumn 91, Issue 3, 1998, Pages 105-112

  Prisco, Domenico ^a,b   Paniccia, Rita ^a   Bandinelli, Brunella ^a   Filippini, Monica ^a   Francalanci, Isa ^a   Giusti, Betti ^a   Giurlani, Letizia ^a   Gensini, Gian Franco ^a   Abbate, Rosanna ^a   Serneri, Gian Gastone Neri ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Clin Medica Generale e Cardiologia   (Italy)

Author keywords

Blood pressure; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; n 3 polyunsaturated fatty acids; Phosphatidylcholine

Indexed keywords

OMEGA 3 FATTY ACID;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; FAT INTAKE; HUMAN; HYPERTENSION; PRIORITY JOURNAL;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIETARY FATS, UNSATURATED; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLANT OILS;

EID: 0032144289     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00046-2     Document Type: Article

References (28)

1. Margolin G, Huster G, Glueck CJ, Speiser J, Vandergrift J, Illig E, Wu J, Streicher P, Tracy T. Blood pressure lowering in elderly subjects: A double-blind crossover study of omega-3 and omega-6 fatty acids. Am J Clin Nutr 1991;53: 562-72.
2. Knapp HR. Omega-3 fatty acids, endogenous prostaglandins, and blood pressure regulation in humans. Nutr Rev 1989;47:301-13.
3. Knapp HR. n-3 fatty acids and human hypertension. Curr Opin Lipidology 1996;7:30-3.
4. Appel LJ, Miller ER III, Seidler JJ, Whelton PK. Does supplementation of diet with "fish oil" reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-38.
5. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-33.
6. Bonaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med 1990; 322:795-801.
7. Tichelaar HY. Eicosapentaenoic acid composition of different fish oil concentrates. Lancet 1990;336:1450-2.
8. Nordoy A, Barstad L, Connor WE, Hatcher L. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans. Am J Clin Nutr 1991; 53:1185-90.
9. WHO/ISH. Memorandum from the WHO/ ISH: 1986 guidelines for the treatment of mild hypertension. Hypertension 1986;8:957-61.
10. Frohlich ED, Grim C, Labarthe DR. Recommendations for human blood pressure determination by sphygmomanometers. Circulation 1988;77:502A-14A.
11. Dart AM, Riemersma RA, Oliver MF. Effects of Maxepa on serum lipids in hypercholesterolemic subjects. Atherosclerosis 1989;80:119-24.
12. Modesti PA, Gensini GF, Conti C, Neri Serneri GG. Clinical evaluation of a blood pressure monitoring device. J Clin Hypertens 1987;3: 631-44.
13. Prisco D, Filippini M, Francalanci I, Paniccia R, Gensini GF, Abbate R, Neri Serneri GG. Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes. Am J Clin Nutr 1996; 63:925-32.
14. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;266:497-509.
15. Schlager SI, Jordi H. Separation of cellular phospholipid, neutral lipid and cholesterol by high-pressure liquid chromatography. Biochim Biophys Acta 1981;665:355-8.
16. Brunner HR, Waeber B, Nussberger J. Blood pressure recording in the ambulatory patient and evaluation of the cardiovascular risk. Clin Sci 1985;68:485-8.
17. Porchet M, Bussien JP, Waeber B, Nussberger J, Brunner HR. Unpredictability of blood pressure recorded outside the clinic in the treated hypertensive patient. J Cardiovasc Pharmacol 1986;8:332-5.
18. White WB, Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. Am J Cardiol 1989;63:94-8.
19. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA 1983;249:2792-8.
20. Pickering TG, James GD, Boddie C, Harshfield GA, Blanks S, Laragh JK. How common is white coat hypertension? JAMA 1988;259: 225-8.
21. Sokolow M, Werdegard D, Kain HK, Hinman AT. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 1966;34:279-98.
22. Poirer L, Cleroux J, Lefebvre J, Yardley C, Lacourciere Y. Usefulness of ambulatory blood pressure monitoring in detecting the additional antihypertensive effect of non-pharmacologic treatment. Blood Pressure Monitoring 1996; 1:33-8.
23. Levinson PD, Iosiphidis AH, Saritelli AL, Herbert PN, Steiner M. Effects of n-3 fatty acids in hypertension. Am J Hypert 1990;3:754-60.
24. Meland E, Fugelly P, Laerum E, Ronneberg R, Sandwick L. Effect of fish oil on blood pressure and blood lipids in men with mild to moderate hypertension. Scand J Prim Health Care 1989; 7:131-5.
25. Knapp HR, Fitzgerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid composition supplements in essential hypertension. N Engl J Med 1989;320:1037-43.
26. Radak K, Deck C, Huster H. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. Arch Intern Med 1991;151:1173-80.
27. Norris P, Jones C, Weston M. Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. BMJ 1986;293:104-5.
28. Harris WS. Fish oil and plasma lipids and lipoprotein metabolism in humans: A critical review. J Lipid Res 1989;30:785-807.